Diverting Ileostomy & Anal Functional Outcomes After Anus Preservation

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06042946` - Microsurgical Resection of Intramedullary Spinal Cord Metastases
Completed	`NCT04642651` - Dexmedetomidine as an Adjuvant for Femoral Nerve Block and Functional Recovery After Total Knee Arthroplasty	Phase 4
Recruiting	`NCT05034341` - Does Prehabilitation Improve Outcomes in Patients Undergoing Complex Spine Fusion Surgery?	N/A
Completed	`NCT03948542` - Fractures of the Humeral Shaft With Primary Radial Nerve Palsy

See also

Status

Clinical Trial

Phase

Recruiting

NCT06042946 - Microsurgical Resection of Intramedullary Spinal Cord Metastases

Completed

NCT04642651 - Dexmedetomidine as an Adjuvant for Femoral Nerve Block and Functional Recovery After Total Knee Arthroplasty

Phase 4

Recruiting

NCT05034341 - Does Prehabilitation Improve Outcomes in Patients Undergoing Complex Spine Fusion Surgery?

N/A

Completed

NCT03948542 - Fractures of the Humeral Shaft With Primary Radial Nerve Palsy

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04776421
Study type	Observational
Source	The First Hospital of Jilin University
Contact	Quan Wang, Prof.
Phone	+86-431-81875602
Email	wquan@jlu.edu.cn
Status	Not yet recruiting
Phase
Start date	April 1, 2021
Completion date	March 1, 2023

Diverting Ileostomy and Anal Functional Outcomes After Anus Preservation Surgery

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms